Skip to main content
Erschienen in: Cancer Causes & Control 6/2010

01.06.2010 | Original paper

Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies

verfasst von: Elizabeth A. Platz, Siobhan Sutcliffe, Angelo M. De Marzo, Charles G. Drake, Nader Rifai, Ann W. Hsing, Ashraful Hoque, Marian L. Neuhouser, Phyllis J. Goodman, Alan R. Kristal

Erschienen in: Cancer Causes & Control | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Data on long-term intra-individual variability in high-sensitivity C-reactive protein (hsCRP) are needed to determine whether one measurement adequately reflects usual levels in prospective studies of on the etiology of cancer and other chronic diseases; when not reflective, the ability to statistically detect modest to moderate associations is reduced. The authors estimated the size of this source of variability and consequent attenuation of the relative risk (RR).

Methods

High-sensitivity C-reactive protein (hsCRP) concentration was measured using a high-sensitivity immunoturbidometric assay in sera collected at years 2, 4, and 6 from 50 men in the placebo arm of the Prostate Cancer Prevention Trial (PCPT). After natural logarithm-transformation of hsCRP, analysis of variance was used to estimate the within- and between-individual variances from which the intra-class correlation coefficient (ICC) was calculated.

Results

The observed RR due to an ICC < 1 was calculated by e(ln true RR*ICC) for a range of true RRs. The 4-year ICC was 0.66. Measuring hsCRP once and assuming no other error, if the true RRs were 1.50, 2.00, and 3.00 when comparing high with low concentration, then the observed RRs would be 1.31, 1.58, and 2.06, respectively.

Conclusion

Investigators planning to measure hsCRP only once should design adequately sized studies to preserve inferences for hypothesized modest to moderate RRs.
Literatur
1.
Zurück zum Zitat Tsimikas S, Willerson JT, Ridker PM (2006) C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47:C19–C31CrossRefPubMed Tsimikas S, Willerson JT, Ridker PM (2006) C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47:C19–C31CrossRefPubMed
2.
Zurück zum Zitat Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123:1133–1140CrossRefPubMed Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123:1133–1140CrossRefPubMed
3.
Zurück zum Zitat Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403–433PubMed Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403–433PubMed
4.
Zurück zum Zitat Thompson I, Goodman P, Tangen C, Lucia M, Miller G, Ford L et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224CrossRefPubMed Thompson I, Goodman P, Tangen C, Lucia M, Miller G, Ford L et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224CrossRefPubMed
5.
Zurück zum Zitat Rosner B, Spiegelman D, Willett WC (1992) Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol 136:1400–1413PubMed Rosner B, Spiegelman D, Willett WC (1992) Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol 136:1400–1413PubMed
6.
Zurück zum Zitat Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE (1995) Reproducibility of plasma hormone levels in postmenopausal women over a 2–3-year period. Cancer Epidemiol Biomarkers Prev 4:649–654PubMed Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE (1995) Reproducibility of plasma hormone levels in postmenopausal women over a 2–3-year period. Cancer Epidemiol Biomarkers Prev 4:649–654PubMed
7.
Zurück zum Zitat Clark GH, Fraser CG (1993) Biological variation of acute phase proteins. Ann Clin Biochem 30(Pt 4):373–376PubMed Clark GH, Fraser CG (1993) Biological variation of acute phase proteins. Ann Clin Biochem 30(Pt 4):373–376PubMed
8.
Zurück zum Zitat de Maat MPM, de Bart ACW, Hennis BC, Meijer P, Havelaar AD, Mulder PGH et al (1996) Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in health, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol 16:1156–1162PubMed de Maat MPM, de Bart ACW, Hennis BC, Meijer P, Havelaar AD, Mulder PGH et al (1996) Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in health, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol 16:1156–1162PubMed
9.
Zurück zum Zitat Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43:52–58PubMed Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43:52–58PubMed
10.
Zurück zum Zitat Sakkinen PA, Macy EM, Callas PW, Cornell ES, Hayes TE, Kuller LH et al (1999) Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. Am J Epidemiol 149:261–267PubMed Sakkinen PA, Macy EM, Callas PW, Cornell ES, Hayes TE, Kuller LH et al (1999) Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. Am J Epidemiol 149:261–267PubMed
11.
Zurück zum Zitat Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E (2001) Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444–450PubMed Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E (2001) Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444–450PubMed
12.
Zurück zum Zitat Nasermoaddeli A, Sekine M, Kagamimori S (2006) Intra-individual variability of high-sensitivity C-reactive protein: age-related variations over time in Japanese subjects. Circ J 70:559–563CrossRefPubMed Nasermoaddeli A, Sekine M, Kagamimori S (2006) Intra-individual variability of high-sensitivity C-reactive protein: age-related variations over time in Japanese subjects. Circ J 70:559–563CrossRefPubMed
13.
Zurück zum Zitat Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D et al (2007) Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 16:2464–2470CrossRefPubMed Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D et al (2007) Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 16:2464–2470CrossRefPubMed
14.
Zurück zum Zitat Shemesh T, Rowley KG, Jenkins AJ, Best JD, O’Dea K (2009) C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian Aboriginal cohort. Clin Chem 55:336–341CrossRefPubMed Shemesh T, Rowley KG, Jenkins AJ, Best JD, O’Dea K (2009) C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian Aboriginal cohort. Clin Chem 55:336–341CrossRefPubMed
15.
Zurück zum Zitat Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E (1999) Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100:230–235PubMed Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E (1999) Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100:230–235PubMed
16.
Zurück zum Zitat Kayaba K, Ishikawa S, Gotoh T, Nago N, Kajii E, Nakamura Y et al (2000) Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: the Jichi Medical School Cohort Study at Yamato, 1993–1998. Jpn Circ J 64:303–308CrossRefPubMed Kayaba K, Ishikawa S, Gotoh T, Nago N, Kajii E, Nakamura Y et al (2000) Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: the Jichi Medical School Cohort Study at Yamato, 1993–1998. Jpn Circ J 64:303–308CrossRefPubMed
17.
Zurück zum Zitat Koenig W, Sund M, Frohlich M, Lowel H, Hutchinson WL, Pepys MB (2003) Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. Am J Epidemiol 158:357–364CrossRefPubMed Koenig W, Sund M, Frohlich M, Lowel H, Hutchinson WL, Pepys MB (2003) Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. Am J Epidemiol 158:357–364CrossRefPubMed
18.
Zurück zum Zitat Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397CrossRefPubMed Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397CrossRefPubMed
19.
Zurück zum Zitat Al-Delaimy WK, Jansen EH, Peeters PH, van der Laan JD, van Noord PA, Boshuizen HC et al (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11:370–382CrossRefPubMed Al-Delaimy WK, Jansen EH, Peeters PH, van der Laan JD, van Noord PA, Boshuizen HC et al (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11:370–382CrossRefPubMed
20.
Zurück zum Zitat Glynn RJ, Macfadyen JG, Ridker PM (2009) Tracking of high-sensitivity C-reactive protein after observation of an initially increased concentration: the JUPITER Study. Clin Chem 55:305–312CrossRefPubMed Glynn RJ, Macfadyen JG, Ridker PM (2009) Tracking of high-sensitivity C-reactive protein after observation of an initially increased concentration: the JUPITER Study. Clin Chem 55:305–312CrossRefPubMed
Metadaten
Titel
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies
verfasst von
Elizabeth A. Platz
Siobhan Sutcliffe
Angelo M. De Marzo
Charles G. Drake
Nader Rifai
Ann W. Hsing
Ashraful Hoque
Marian L. Neuhouser
Phyllis J. Goodman
Alan R. Kristal
Publikationsdatum
01.06.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 6/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9511-z

Weitere Artikel der Ausgabe 6/2010

Cancer Causes & Control 6/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.